Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cellink AB (publ)

49Z
Current price
3.4 EUR +0.12 EUR (+3.66%)
Last closed 3.28 EUR
Company
ISIN SE0013647385
Sector Healthcare
Industry Medical Devices
Exchange Frankfurt Exchange
Capitalization 244 293 590 EUR
Yield for 12 month +7.97 %
1Y
3Y
5Y
10Y
15Y
49Z
21.11.2021 - 28.11.2021

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden. Address: LAngfilsgatan 9, Gothenburg, Sweden, 412 77

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+195 015 085 EUR

Last Year

+194 113 641 EUR

Current Quarter

+46 285 637 EUR

Last Quarter

+44 231 387 EUR

Current Year

+145 574 396 EUR

Last Year

+158 671 325 EUR

Current Quarter

+23 836 236 EUR

Last Quarter

+19 944 429 EUR

Key Figures 49Z

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 71 972 732 EUR
Operating Margin TTM -9.35 %
PE Ratio
Return On Assets TTM -3.05 %
PEG Ratio
Return On Equity TTM -33.3 %
Wall Street Target Price
Revenue TTM 2 419 122 270 EUR
Book Value 41.71 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -0.6 %
Dividend Yield
Gross Profit TTM 1 869 893 520 EUR
Earnings per share -1.86 EUR
Diluted Eps TTM -1.86 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -63.87 %

Dividend Analytics 49Z

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 49Z

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 4:1
Payout Ratio
Last Split Date 10.01.2020
Dividend Date

Stock Valuation 49Z

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.8042
Price Sales TTM 0.101
Enterprise Value EBITDA 0.929
Price Book MRQ 0.9511

Financials 49Z

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 49Z

For 52 weeks

2.44 EUR 6.33 EUR
50 Day MA 3.84 EUR
Shares Short Prior Month
200 Day MA 3.91 EUR
Short Ratio
Shares Short
Short Percent